Urinary NT-proBNP compared head-to-head to plasmatic NT-proBNP in a real life collective with an ICD.


Journal

Indian pacing and electrophysiology journal
ISSN: 0972-6292
Titre abrégé: Indian Pacing Electrophysiol J
Pays: Netherlands
ID NLM: 101157207

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 16 11 2023
revised: 12 08 2024
accepted: 22 10 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 26 10 2024
Statut: aheadofprint

Résumé

Plasma NT-proBNP is an established marker of heart failure. Previous studies suggested urinary NT-proBNP has potential as marker of chronic heart failure as well. The objective of this study was to compare urinary NT-proBNP to plasma NT-proBNP in a real-life collective of patients with an ICD, especially regarding ICD-therapies. NT-proBNP was assessed in plasma and fresh spot urine (the latter related to urinary creatinine) from 322 patients of our ICD outpatient clinic. 54 healthy individuals served as a control group. Follow-up regarding mortality and ICD therapies was performed after 32 months (IQR 5- 35 months). Plasma and urinary NT-proBNP was positively correlated (r=0.89, p<0,001). According to ROC analysis urinary NT-proBNP detected LV dysfunction (EF<35% vs. healthy CTRL) with very satisfying predictive values (AUC 0.95), but plasma NT-proBNP showed slightly better values (AUC 0.99). Patients who received appropriate ICD-shock-therapies showed significantly higher plasma (p<0.001) as well as urinary NT-proBNP levels (p=0.011) compared to patients without shock-therapy. In Kaplan-Meier analysis, plasma as well as urinary NT-proBNP levels > Youden-Index showed significantly higher event rates for appropriate ICD-shock therapies (p<0.001 and p=0.016) and the combined endpoint of all-cause-mortality and shock therapies (each p<0.001). Urinary and plasma NT-proBNP were independent predictors for appropriate ICD-shock-therapies and for the combined endpoint of all-cause mortality and appropriate ICD-shock-therapies (each p<0.001). Urinary NT-proBNP as a marker for LV dysfunction and symptomatic heart failure showed promising predictive values. Associations between plasma as well as urinary NT-proBNP and ICD shock-therapies could be shown.

Identifiants

pubmed: 39461716
pii: S0972-6292(24)00150-5
doi: 10.1016/j.ipej.2024.10.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright © 2024 Indian Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Benedikt Seither (B)

University Hospital Regensburg.

Alexander Schober (A)

University Hospital Regensburg. Electronic address: alexander.schober@ukr.de.

Raphael Allgaier (R)

University Hospital Regensburg.

Christine Meindl (C)

University Hospital Regensburg.

Michael Paulus (M)

University Hospital Regensburg.

Ute Hubauer (U)

University Hospital Regensburg.

Andreas Schober (A)

University Hospital Regensburg.

Ekrem Ücer (E)

University Hospital Regensburg.

Sabine Fredersdorf (S)

University Hospital Regensburg.

Petra Lehn (P)

University Hospital Regensburg.

Andreas Keyser (A)

University Hospital Regensburg.

Andreas Luchner (A)

Hospital Barmherzige Brüder, Regensburg.

Lars Maier (L)

University Hospital Regensburg.

Stefan Wallner (S)

University Hospital Regensburg.

Carsten Jungbauer (C)

University Hospital Regensburg.

Classifications MeSH